![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/5025 | (2006.01) |
A61K 31/506 | (2006.01) | ||
A61K 31/517 | (2006.01) | ||
A61K 31/519 | (2006.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 31/541 | (2006.01) | ||
A61K 31/553 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/02 | (2006.01) | ||
A61K 9/00 | (2006.01) |
(11) | Number of the document | 3849534 |
(13) | Kind of document | T |
(96) | European patent application number | 19858883.2 |
Date of filing the European patent application | 2019-09-09 | |
(97) | Date of publication of the European application | 2021-07-21 |
(45) | Date of publication and mention of the grant of the patent | 2025-03-05 |
(46) | Date of publication of the claims translation | 2025-05-12 |
(86) | Number | PCT/US2019/050224 |
Date | 2019-09-09 |
(87) | Number | WO 2020/055755 |
Date | 2020-03-19 |
(30) | Number | Date | Country code |
201862729169 P | 2018-09-10 | US |
(72) |
ENGSTROM, Lars, Daniel , US
ARANDA, Ruth, Wei , US
OLSON, Peter , US
CHRISTENSEN, James, Gail , US
|
(73) |
Mirati Therapeutics, Inc. ,
Route 206 and Province Line Road, Princeton, New Jersey 08543,
US
|
(74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Dasatinibo ir adagrasibo derinys, skirtas panaudoti nesmulkialąstelinio plaučių vėžio gydymui |
COMBINATION OF DASATINIB AND ADAGRASIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER |
Payment date | Validity (years) | Amount | |
2025-08-04 | 7 | 162.00 EUR |
2026-09-09 |